Elena B. Pavlova

Elena B. Pavlova

Auto-generated profile, based on publicly available information

Elena B. Pavlova

Saint Petersburg State Pediatric Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2020 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
JHJ. K. Hakizimana
J. K. Hakizimana
VTViladimir Timchenko
Viladimir Timchenko
MSM. A. Shakmaeva
M. A. Shakmaeva
TKT. A. Kaplina
T. A. Kaplina
MSM. D. Subbotina
M. D. Subbotina
NPN. V. Pavlova
N. V. Pavlova
EBV-mononucleosis is a widespread infectious disease, and also it is an urgent problem of the whole world. The purpose of the research was to study the clinical and laboratory features of EBV-mononucleosis in hospitalized children of different ages in modern conditions. Under the supervision were 136 children aged from 1 year to 18 years. All of the patients had typical and mainly (85%) moderate form of the disease, and 15% of them patients had a severe form of the disease. The results: more severe fever and lymphadenopathy were observed in children older than 3 years. Acute tonsillitis was present in all hospitalized children. Adenoiditis and hepatosplenomegaly were greater in the group of patients of a younger age. Hyperfermentemia was determined in more than half of patients, more often in children over 12 years old. In the hemogram leukocytosis and monocytosis were mostly noted. Atypical blood mononuclear cells were detected in 89% of patients. Patients got complex etiopathogenetic therapy.

24 June 2023 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
TCT. M. Chernova
T. M. Chernova
DIDmitri O. Ivanov
Dmitri O. Ivanov
EPE. B. Pavlova
E. B. Pavlova
VTViladimir Timchenko
Viladimir Timchenko
EBE. V. Barakina
E. V. Barakina
KMK. D. Murasheva
K. D. Murasheva
Влияние пандемии COVID-19 на инфекционную заболеваемость у детей в условиях мегаполиса

28 December 2021 in Acta Biomedica Scientifica
Verified
Journal Article
Open access
PDF file
TCT. M. Chernova
T. M. Chernova
EPE. B. Pavlova
E. B. Pavlova
VTViladimir Timchenko
Viladimir Timchenko
EEE. O. Ermakova
E. O. Ermakova
SUS. Yu. Uskova
S. Yu. Uskova
AZA. A. Zherebtsova
A. A. Zherebtsova
Background. The use of antiviral agents can shorten the duration of the viral infection. The aim: to study the clinical and epidemiological features and the effectiveness of antiviral therapy for new coronavirus infection (COVID-19) in outpatient children.Materials and methods. From April 2020 to March 2021, 9334 outpatient children aged from 0 months to 17 years were randomly tested for new coronavirus infection. SARS-CoV-2 RNA was detected in oropharyngeal and nasal material by PCR. Patients with confirmed new coronavirus infection were prescribed interferon-alpha (IFN-α) intranasally, antiviral agents of systemic action. The control group consisted of children with COVID-19 who did not receive treatment.Results. When examining clinically healthy contact children, SARS-CoV-2 RNA was detected in 7.4 % of cases. In the structure of ARI, the specific weight of COVID-19 was 12.3 % with the peak incidence in April-May (up to 22.8 %) and NovemberDecember (up to 30.0 %). In half of the cases, children became infected in the family, and usually adults were the index patient. In 47.7 % of cases, an asymptomatic form of COVID-19 was registered without significant differences in patients of different ages. In one third of children with concomitant pathology, the disease was asymptomatic, in half it was mild, in other cases moderate severity was diagnosed. The clinical picture of COVID-19 did not differ from other ARIs. Anosmia (9.4 %) in half of the cases was combined with ageusia (4.4 %) and was significantly more common in boys. The duration of clinical manifestations in children of the control group and those who received antiviral therapy did not statistically significantly differ in mild and severity of the disease. Also, various antiviral therapy options did not significantly affect the duration of SARS-CoV-2 detection in children with various forms of COVID-19.Conclusion. In the first year of the pandemic, the novel coronavirus infection did not dominate the pattern of respiratory diseases in outpatient children. Further research is required to develop pediatric guidelines for the treatment of COVID-19 at the outpatient stage.

12 August 2022 in Pediatrician (St. Petersburg)
Verified
Journal Article
Open access
PDF file
DIDmitri O. Ivanov
Dmitri O. Ivanov
YPYury V. Petrenko
Yury V. Petrenko
VRVitaly A. Reznik
Vitaly A. Reznik
RNRuslan Abdullaevich Nasyrov
Ruslan Abdullaevich Nasyrov
VTViladimir Timchenko
Viladimir Timchenko
VGVeronika Galichina
Veronika Galichina
Children get sick less often than adults with a new coronavirus infection (in the Russian Federation, they account for 7.6% of registered cases of COVID-19), with less severe clinical symptoms, they require hospitalization less often, their disease is milder. The frequency of severe and extremely severe cases of COVID-19 in children does not exceed 1%. A clinical case of the course of COVID-19 in a child aged 2 years 4 months is presented. with acute lymphoblastic leukemia. A feature of the presented case is the development of an extremely severe new coronavirus infection in a child with secondary immunodeficiency caused by a long-term course of malignant, treatment-resistant of acute lymphoblastic leukemia. Slow, within 3 months, the development of the infectious process with long-term preservation of normal indicators of the function of the respiratory system led to the formation of viral-bacterial pneumonia with the development of respiratory distress syndrome. Despite the modern complex of therapeutic measures, severe comorbidity led to the development of DIC and multiple organ failure, which was the direct cause of the childs death. A possible therapy strategy is discussed in a patient with severe comorbidity against the background of secondary immunodeficiency and long-term persistence of SARS-CoV-2 in the presence of IgG antibodies to SARS-CoV-2 in the blood. For the first time, data on morphological changes in the lungs with a long course of COVID-19 (more than 100 days) in a young child are presented.

10 June 2019 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
TCT.M. Chernova
T.M. Chernova
VTViladimir Timchenko
Viladimir Timchenko
EPE.B. Pavlova
E.B. Pavlova
EBE.V. Baracina
E.V. Baracina
S1Saint Petersburg Saint Petersburg City Children'S Polyclinic No. 11
Saint Petersburg Saint Petersburg City Children'S Polyclinic No. 11
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.

23 March 2024 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
TCT. M. Chernova
T. M. Chernova
DIDmitri O. Ivanov
Dmitri O. Ivanov
OVO. I. Veduta
O. I. Veduta
VTViladimir Timchenko
Viladimir Timchenko
EBE. V. Barakina
E. V. Barakina
AZA. A. Zherebtsova
A. A. Zherebtsova
Even when asymptomatic, intestinal parasitosis can have a significant impact on the health of children. Materials and methods. An analysis of the medical documentation of the children's clinic for 2016—2023 was carried out. Results. It has been established that enterobiasis dominates in children living in St. Petersburg (87.8%—98.8%), the proportion of ascariasis and giardiasis in different years did not exceed 5.2% and 10.0%, respectively. The maximum proportion of those affected by E. vermicularis (50.6%—66.8%) and Giardia (67.3%) was in the age group of 7—14 years, while ascariasis most often affected children 3—6 years old (51.7%). Enterobiasis was more often recorded during annual preventive examinations (September-November) (52.0%—65.9%), ascariasis was detected at a later date — November-January (41.5%), the largest number of episodes of giardiasis was observed in the spring months (53.9%). If helminthic infestations in all cases were asymptomatic and were discovered by chance during a microscopic examination of feces, then in the case of giardiasis, 46.2% of those infected complained of abdominal pain (42.3%), discomfort after eating (25.0%), diarrhea/constipation (21.2%), bloating (19.2%), frequent belching of air (13.5%). Thus, a single microscopic examination of feces is not very informative. Knowledge of the clinical and epidemiological features of parasitic infestations will allow the pediatrician to conduct an in-depth examination of the child to decide on antiparasitic treatment